98 related articles for article (PubMed ID: 22811256)
1. Transient myeloproliferative disorder progression and acquired chromosomal abnormalities in children with Down syndrome.
Picos Cárdenas VJ; Meza Espinoza JP; Garibaldi Covarrubias RF; Barajas Torres RL; González García JR
Pediatr Blood Cancer; 2012 Nov; 59(5):962-3. PubMed ID: 22811256
[No Abstract] [Full Text] [Related]
2. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
3. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
Zipursky A; Brown EJ; Christensen H; Doyle J
Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
[TBL] [Abstract][Full Text] [Related]
4. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
[TBL] [Abstract][Full Text] [Related]
5. Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Norton A; Fisher C; Liu H; Wen Q; Mundschau G; Fuster JL; Hasle H; Zeller B; Webb DK; O'Marcaigh A; Sorrell A; Hilden J; Gamis A; Crispino JD; Vyas P
Blood; 2007 Aug; 110(3):1077-9. PubMed ID: 17644747
[No Abstract] [Full Text] [Related]
6. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
[TBL] [Abstract][Full Text] [Related]
7. Acute leukemias in children with Down syndrome.
Zwaan MC; Reinhardt D; Hitzler J; Vyas P
Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
[TBL] [Abstract][Full Text] [Related]
8. Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder.
Gamis AS; Smith FO
Br J Haematol; 2012 Nov; 159(3):277-87. PubMed ID: 22966823
[TBL] [Abstract][Full Text] [Related]
9. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome and leukemia--an overview of cytogenetic and molecular events.
Savaşan S; Taub JW; Ravindranath Y
Turk J Pediatr; 1997; 39(4):519-31. PubMed ID: 9433155
[No Abstract] [Full Text] [Related]
11. Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCR.
Porta G; Maserati E; Mattarucchi E; Minelli A; Pressato B; Valli R; Zecca M; Bernardo ME; Lo Curto F; Locatelli F; Danesino C; Pasquali F
Leukemia; 2007 Aug; 21(8):1833-5. PubMed ID: 17460707
[No Abstract] [Full Text] [Related]
12. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
[TBL] [Abstract][Full Text] [Related]
13. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
14. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
[TBL] [Abstract][Full Text] [Related]
15. Acute leukemias in children with Down syndrome.
Zwaan CM; Reinhardt D; Hitzler J; Vyas P
Hematol Oncol Clin North Am; 2010 Feb; 24(1):19-34. PubMed ID: 20113894
[TBL] [Abstract][Full Text] [Related]
16. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.
Hasle H; Lund B; Nyvold CG; Hokland P; Østergaard M
Leuk Res; 2006 May; 30(5):543-6. PubMed ID: 16242775
[TBL] [Abstract][Full Text] [Related]
17. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
18. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
[TBL] [Abstract][Full Text] [Related]
19. [Transient myeloproliferative disorder in Down syndrome].
Ito E; Toki T
Nihon Rinsho; 2012 Apr; 70 Suppl 2():687-91. PubMed ID: 23134029
[No Abstract] [Full Text] [Related]
20. [Association of congenital chromosome abnormalities and malignant diseases].
Erzsébet B; Andrea N; Róbert S; Eva O
Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
